Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

KPTI $9.73 2.6100 +36.66%
CCXI $5.26 0.3400 +6.91%
THLD $1.06 0.0500 +4.95%
ARRY $3.60 0.1600 +4.65%
CLVS $24.22 0.8300 +3.55%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

NYMX $3.61 -0.3400 -8.61%
ARGS $4.78 -0.4400 -8.43%
MNKD $0.70 -0.0495 -6.64%
SNSS $0.83 -0.0500 -5.68%
SPHS $3.22 -0.1500 -4.45%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next > | Last >>

Maker Of EpiPen To Sell Generic Version For Half The Price

(NPR/Shots blog) Aug 29, 2016 - Treatment for life-threatening allergic reactions is about to get a little cheaper.
read article 



Edible Sunscreens Are All the Rage, but No Proof They Work

(New York Times/Well blog) Aug 29, 2016 - In New York’s Hamptons, beachgoers pass around the orange sun-protector pills as if it’s a party drug, but there’s no evidence they work.
read article 



Max Ritvo, Poet Who Chronicled His Cancer Fight, Dies at 25

(New York Times) Aug 26, 2016 - Max Ritvo, an accomplished poet who spent much of his life under the cloud of cancer while gaining wide attention writing and speaking about it, died of the disease on Tuesday at his home in Los Angeles. He was 25.
read article 



Sen. Charles Schumer to Propose Cancer Registry for Firefighters

(Wall Street Journal) Aug 28, 2016 - Sen. Charles Schumer said he would propose legislation creating a national registry tracking cancer rates among U.S. firefighters, something he said would help researchers root out toxic building materials.
read article (paid subscription required) 



Researcher to Study a Two-Pronged Approach Against Colorectal Cancers

(UNM Comprehensive Cancer Center) Aug 29, 2016 - Ellen Beswick, PhD, studies a protein that could be key in attacking cancers of the colon and rectum, and possibly other cancers, too
read article 



New NCCN Imaging Appropriate Use Criteria Published For Eight Cancer Types

(NCCN) Aug 29, 2016 - The National Comprehensive Cancer Network® (NCCN®), a Centers for Medicare & Medicaid Services (CMS)-approved provider-led entity for imaging appropriate use criteria (AUC), continues to build its library of AUC and has published NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™) for eight new cancer types.
read press release 



ESC Launches Novel Paper On Tackling Cardiac Toxicity Of Anticancer Therapies

(European Society of Cardiology) Aug 27, 2016 - The European Society of Cardiology has launched a novel position paper, under the auspices of its Committee for Practice Guidelines, on tackling the cardiac toxicity of anticancer therapies.
read press release 



Leap Therapeutics to Acquire Macrocure

(Genetic Engineering & Biotechnology News) Aug 29, 2016 - Leap Therapeutics will acquire Macrocure in a deal intended to create a stronger developer of immune-oncology treatments.
read article (free registration required) 



Cuba's Lung Cancer Vaccine: Hype or Hope?

(Medscape Medical News) Aug 26, 2016 - With relations thawing between the US and Cuba, a lung cancer vaccine has caught the attention of the cancer community and the media.
read article (free registration required) 



Aeglea BioTherapeutics Doses First Patient in Phase 1 Trial of AEB1102 for the Treatment of Hematological Malignancies

(TheStreet) Aug 29, 2016 - Company expands profile of AEB1102 into second cancer type.
read article 



ERYTECH Completes Patient Enrollment in Phase 2b Trial for eryaspase (GRASPA®) in Acute Myeloid Leukemia

(Morningstar) Aug 29, 2016 - ERYTECH Pharma, the French biopharmaceutical company developing ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs, today announced that it has reached full patient enrollment in the Phase 2b trial of eryaspase, also known as ERY-ASP or GRASPA®, for the treatment of acute myeloid leukemia (AML).
read article 



Kadmon Initiates Phase 2 Clinical Trial Evaluating Tesevatinib in Glioblastoma

(Kadmon) Aug 29, 2016 - Kadmon Holdings, Inc. today announced that the first patient has been dosed in a Phase 2 clinical trial of tesevatinib, the Company’s oral tyrosine kinase inhibitor, for the treatment of recurrent glioblastoma.
read corporate press release 



Gradalis®, Inc. Announces Dosing of First Patient in Pilot Study Combining Vigil® Engineered Autologous Tumor Cell Immunotherapy and Durvalumab in Advanced Breast Cancer

(Houston Business Journal) Aug 29, 2016 - Gradalis®, Inc., a clinical-stage biopharmaceutical company, today announced that the first patient has been dosed in a pilot study combining Vigil® Engineered Autologous Tumor Cells (EATCs) with durvalumab in advanced breast cancer.
read article 



Researchers Find A New Way To Identify And Target Malignant Aging In Leukemia

(UC San Diego) Aug 26, 2016 - Discovery involves secondary AML, which particularly afflicts older patients with poor prognoses.
read press release 



Testosterone-Related Genetic Mutation Leads To Deadlier Outcomes In Prostate Cancer

(Cleveland Clinic) Aug 26, 2016 - A collaborative Cleveland Clinic-Mayo Clinic team of researchers has shown for the first time that patients with advanced prostate cancer are more likely to die earlier from their disease if they carry a specific testosterone-related genetic abnormality.
read press release 



UCLA Researchers Develop Method To Speed Up Detection Of Infectious Diseases, Cancer

(UCLA) Aug 26, 2016 - A team of UCLA researchers has found a way to speed and simplify the detection of proteins in blood and plasma opening up the potential for diagnosing the early presence of infectious diseases or cancer during a doctor’s office visit.
read press release 



Pancreatic Cancer Trial To Make Tumours More Sensitive To Treatment

(Cancer Research UK) Aug 29, 2016 - Cancer Research UK launches a first-of-its-kind pancreatic cancer clinical trial to make cancer cells more responsive to chemotherapy and radiotherapy.
read press release 



The First Epigenetic Test To Diagnose Tumors Of Unknown Origin

(IDIBELL [Barcelona, Spain]) Aug 27, 2016 - The EPICUP® test is a new tool that helps identify up to 87% of cases of cancer of unknown origin (CUP).
read article 



To Help Patients, Lawmakers Pushed Access To A Controversial Doctor, Documents Show

(STAT/Special Report) Aug 29, 2016 - The call to Congressman Ted Yoho’s office was a matter of life and death: A constituent was seeking help for a 5-year-old great-nephew who was suffering from a terrible brain tumor.
read article 



CTI BioPharma Announces Top-Line Results From PERSIST-2 Phase 3 Trial Of Pacritinib For High-Risk Patients With Advanced Myelofibrosis

(Yahoo! Finance) Aug 29, 2016 - CTI BioPharma Corp. today announced top-line results from PERSIST-2, a randomized, controlled Phase 3 clinical trial comparing pacritinib, an investigational oral multikinase inhibitor, with physician-specified best available therapy (BAT), including ruxolitinib, for the treatment of patients with myelofibrosis whose platelet counts are less than 100,000 per microliter -- a patient population with high-risk advanced disease.
read article 



An Alarming Number Of Scientific Papers Contain Excel Errors

(Washington Post/Wonkblog) Aug 26, 2016 - A surprisingly high number of scientific papers in the field of genetics contain errors introduced by Microsoft Excel, according to an analysis recently published in the journal Genome Biology.
read article (free registration required) 



FDA Suggests Testing All Donated Blood for Zika

(NBC News) Aug 26, 2016 - All blood donations should be tested for the Zika virus, the Food and Drug Administration said Friday.
read article 



Burden of Health-Care Costs Moves to the Middle Class

(Wall Street Journal) Aug 25, 2016 - Rising out-of-pocket health care costs ‘means less money for other things’.
read article (paid subscription required) 



1-Year Grace Period for ICD-10 Coding to End Soon

(Medscape Medical News) Aug 26, 2016 - Physicians will no longer be able to choose an unspecified diagnostic code when the clinical documentation supports a more specific one; just be in the right family of codes.
read article (free registration required) 



ACOs Save Medicare $466M Last Year But Quality Improvements Are Mixed

(KHN Morning Briefing) Aug 26, 2016 - The Centers for Medicare & Medicaid Services announces that a third of the accountable care organizations will receive bonuses, which are awarded in part on performance and quality marks. ACOs care for about 7.7 million Medicare beneficiaries.
read article